SCHEMBL1609329

SCHEMBL1609329

COC(=O)c1nc(C2CC2)nc(N(C)Cc2cc(OC)cc(OC)c2)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.41
STAT1 P42224 1/20 0.36
CHRM3 P20309 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
PPARG P37231 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
MTNR1A P48039 2/20 0.34
MTNR1B P49286 2/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12713250 0.94 PDE10A (0.40) PDE10ASTAT1CHRM3PDE4APDE4B
SCHEMBL1610220 0.90 MTNR1A (0.42) PDE10ASTAT1CHRM3PDE4APDE4B
SCHEMBL1610429 0.90 PDE10A (0.41) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1609979 0.85 PDE4B (0.42) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1610432 0.84 TSHR (0.40) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1609421 0.84 PDE10A (0.43) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1609728 0.84 PDE10A (0.42) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL12713237 0.84 PDE10A (0.41) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1609602 0.84 PDE4B (0.41) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL12713104 0.84 PDE4B (0.43) PDE10ACHRM3PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 PDE10A 1704/4885STAT1 2775/4885CHRM3 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.